Indoles

Sep 20, 2017

PharmaMar Starts Clinical Studies with a New Compound -PM14- in Patients with Solid Tumors

Jun 28, 2017

Thermo Fisher Scientific Announces Availability of Two New Immunoassays Designed to Maximize Detection of Synthetic Cannabinoids

Jun 07, 2017

Promius Pharma Announces Positive Results for Phase 2 Study of DFN-02, a Novel Intranasal Formulation of Sumatriptan

Jun 07, 2017

Promius Pharma to Present Innovative Scientific Results From Migraine Studies at the 59th Annual Scientific Meeting of the American Headache Society

Jun 05, 2017

Blueprint Medicines Announces New Phase 1 Clinical Data for BLU-285 in Advanced Gastrointestinal Stromal Tumors and Plans to Pursue Expedited Development in Patients with a PDGFRa D842V Mutation